Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting

References

• Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108–31.
   PubMed Web of Science ®Google Scholar
• Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987;28:1307–18.
   PubMed Web of Science ®Google Scholar
• Villani AC, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010;138:1502–13.
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Palssan O, Jones KR. Systemic review of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2007;133:799–807.
   PubMedGoogle Scholar
• Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002;51:410–13.
   PubMed Web of Science ®Google Scholar
• Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together. J Pediatr Gastrtoenterol Nutr 2007;45:115–19.
   PubMed Web of Science ®Google Scholar
• Kristjánsson G, Venge P, Wanders A, Loof L, Hallgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806–12.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J. Gastroenterol. Hepatol 2008;23:1689–94.
   PubMed Web of Science ®Google Scholar
• Tobias L, Adam B, Bredack C, Roth A, Heinzel S, Lesster S, Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913–20.
   PubMedGoogle Scholar
• Malefyt RdeW, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Environ Monit 1991;174:1209–20.
   Google Scholar
• Dinan TG, Quigley EM, Ahmed SM, Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006;130:304–11.
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Collins MS. Is irritable bowel syndrome a low–grade inflammatory bowel disease. Gastroenterol Clin North Am 2005;34:235–45.
   PubMed Web of Science ®Google Scholar
• Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:9642–7.
   Google Scholar
• Wedemeyer N, Potter T, Wetzlich S, Göhde W. Flow cytometric quantification of competitive reverse transcription-PCR products. Clin Chem 2002;48:1398–405.
   PubMed Web of Science ®Google Scholar
• Vigano P, Somigliana E, Mangioni S, Vignali M, Vignali M, Di Blasio AM. Expression of Interleukin -10 and its receptor is up-regulated in early pregnant versus cycling human endometrium. J Clin Endocrinol Metab 2002;87:5730–6.
   PubMed Web of Science ®Google Scholar
• Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute shigella infection – an observation in a small case control study. Yonsei Med J 2010;51:1976–2437.
   Web of Science ®Google Scholar
• Scully P, McKernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. This article is not included in your organization's subscription. However, you may be able to. Am J Gastroenterol 2010;105:2235–43.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, Mclaren A, Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449–57.
   PubMed Web of Science ®Google Scholar
• Wang LH, Fang X C, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096–101.
   PubMed Web of Science ®Google Scholar
• Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008;100:49–53.
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease. Gastroenterol Clin North Am 2005;34:235–45.
   PubMed Web of Science ®Google Scholar
• Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989;143:1366–71.
   PubMed Web of Science ®Google Scholar
• Malefyt RdeW, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:51209–20.
   Web of Science ®Google Scholar
• Shefler I, Salamon P, Reshef T, Mor A, Mekori YA. T Cell-induced mast cell activation: a role for microparticles released from activated t cells. J Immunol 2010;185:4206–12.
   PubMed Web of Science ®Google Scholar
• Kim GY, Lee JW, Ryu HC, Wei JD, Seong CM, Kim JH. Proinflammatory cytokine IL-1β stimulates IL-8 synthesis in Mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol 2010;184:3946–54.
   PubMed Web of Science ®Google Scholar
• Carvalho RFDS, Nilsson G, Harvima IT. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation. Exp Dermatol 2010;192:117–22.
   Google Scholar
• Blatner NR, Bonertz A, Beckhove P, Cheon EC, Krantz SB, Strouch M, In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. PNAS 2010;107:6430–5.
   PubMed Web of Science ®Google Scholar
• Rozell MD, Erger RA, Casale TB. Isolation technique alters eosinophil migration response to IL-8. J Immunol Methods 1996;197:97–107.
   PubMed Web of Science ®Google Scholar
• Furuta GT, Ackerman SJ, Varga J, Spiess AM, Wang MY, Wershil BK. Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol 2000;122:35–40.
   PubMed Web of Science ®Google Scholar